Collaboration Advances DNA-delivered Antibodies to Prevent COVID-19 Philadelphia, PA, July 07, 2022 (GLOBE NEWSWIRE) -- PHILADELPHIA — (July 7, 2022) — Under a Defense Advanced Research Projects Agency (DARPA) and Joint Program Executive Office for Chemical,...

The Wistar Institute Cancer Center to be Renamed with $10 Million Gift from Caplan Family to Advance Cancer Research Philadelphia, March 08, 2022 (GLOBE NEWSWIRE) -- The Wistar Institute announces that Ronald Caplan, founder and president of PMC Property Group, Inc., and his wife Ellen have donated $10 million to...

Wistar Reports New Class of Antibiotics Active Against a Wide Range of Bacteria PHILADLEPHIA, Dec. 23, 2020 (GLOBE NEWSWIRE) -- Wistar Institute scientists have discovered a new class of compounds that uniquely combine direct antibiotic killing of pan drug-resistant bacterial...

DARPA and JPEO-CBRND Award $37.6M to The Wistar Institute and Collaborators at INOVIO, AstraZeneca, Penn, & Indiana University to Develop Innovative COVID-19 Treatment PHILADELPHIA, Dec. 15, 2020 (GLOBE NEWSWIRE) -- A team of scientists from The Wistar Institute, INOVIO, AstraZeneca, the Perelman School of Medicine at the University of Pennsylvania, and Indiana...